The Pattern of Dyslipidemia in Chronic Liver Disease Patients.

Autor:	Farooque U; Neurology, Dow University of Health Sciences, Karachi, PAK., Lohano AK; Medicine, Peoples University of Medical and Health Sciences for Women, Nawabshah, PAK., Dahri Q; Internal Medicine, Peoples University of Medical and Health Sciences for Women, Nawabshah, PAK., Arain N; Internal Medicine, Peoples University of Medical and Health Sciences for Women, Nawabshah, PAK., Farukhuddin F; Neurology, University Hospital Cleveland Medical Center, Cleveland, USA., Khadke C; Internal Medicine, Rural Medical College, Pravara Institute of Medical Sciences, Loni, IND., Prince F; Emergency Medicine, Medical University of Lublin, Lublin, POL., Farooque R; Internal Medicine, Sindh Medical College, Karachi, PAK., Shehata MA; Medicine and Surgery, Alexandria Faculty of Medicine, Alexandria, EGY., Bin Zafar MD; Internal Medicine, Dow University of Health Sciences, Civil Hospital Karachi, Karachi, PAK.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2021 Feb 10; Vol. 13 (2), pp. e13259. Date of Electronic Publication: 2021 Feb 10.
DOI:	10.7759/cureus.13259
Abstrakt:	Introduction Patients with chronic liver disease are expected to report derangements in serum lipid profiles. Lipid profile monitoring is not a part of the routine management of these patients in our hospital. Few recent studies show how lipid profile varies with the severity of disease and should be considered in the management planning of such patients. The objective of this study was to determine the pattern of dyslipidemia in chronic liver disease patients. Materials and methods A cross-sectional study was conducted involving 171 patients of all genders aged between 18 years and 60 years presenting with chronic liver disease with disease severity graded on Child-Pugh class as A, B, and C. Lipid profile was acquired in all these patients and was compared across various subgroups. Individual serum lipid parameters were graded as normal, high, or very high. Each patient was required to provide written informed consent. Statistical Package for Social Sciences (SPSS) version 21.0 (IBM Corp. Armonk, NY) was used to analyze data statistically, taking a p-value of ≤0.05 as significant. Results The mean age of patients was 51.2±7.3 years. The male to female ratio came out to be 1.5:1, with 103 (60.2%) male and 68 (39.8%) female patients included in the study. The disease was classified as Child-Pugh A in 20 (11.7%) patients, Child-Pugh B in 67 (39.2%) patients, and Child-Pugh C in 84 (49.1%) patients. Forty-four (25.7%) patients were hypertensive while 62 (36.3%) were diabetic. The mean body mass index (BMI) of these patients was 25.9±2.4 kg/m 2 . Mean serum values among Child-Pugh A, Child-Pugh B, and Child-Pugh C of low-density lipoproteins (LDL) (113.15±14.08 vs. 95.58±14.25 vs. 53.46±5.90 mg/dl; p-value 0.001), high-density lipoproteins (HDL) (50.60±3.19 vs. 40.70±2.95 vs. 35.40±3.88 mg/dl; p-value 0.001), total cholesterol (174.20±17.33 vs. 164.00±17.82 vs. 128.64±24.73 mg/dl; p-value 0.001), and triglycerides (127.15±8.98 vs. 100.84±27.12 vs. 93.36±25.56 mg/dl; p-value 0.001) decreased significantly with increasing severity of disease. Nineteen (11.1%) patients had hyperlipidemia (serum values of two or more parameters above normal) while 152 (88.9%) patients had normal lipid profile. When stratified, no statistically significant difference was found in the frequency of hyperlipidemia across various subgroups based on the patient's gender, age, duration, and severity of the disease, BMI, or diabetic and hypertensive status. Conclusions A substantial proportion of patients with chronic liver disease had hyperlipidemia which varied with the severity of disease on Child-Pugh classification. Routine monitoring of the lipid profile of such patients is necessary for timely identification and management of dyslipidemia to improve the outcome of such patients. It also suggests an important role of lipid profile in the risk stratification and treatment of chronic liver disease patients and warrants further studies in this regard. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2021, Farooque et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu